03/11/2025 05:33
FPT Signs a $67 Million Framework Agreement with KMP Aryadhana for a Five-Year Partnership

Global IT firm FPT officially signed a USD 67 million Master Service Agreement with KMP Aryadhana, Indonesia's leading cooperative for innovation. The signing ceremony took place on the occasion of the official state visit of Vietnam's Communist Party General Secretary H.E. To Lam to Indonesia, marking a significant milestone in the strategic partnership between the two parties, as well as both nations. This press release features multimedia. View the full release here: https://www.businesswire...

03/18/2025 06:00
Protembis Announces Formation of New Scientific Advisory Board Comprised of World-Renowned Structural Heart Experts

Protembis, a privately-held emerging cardiovascular medical device company, announced today the establishment of a Scientific Advisory Board (SAB) to provide objective advice and contribute to the strategic plans of the company. Specifically, the SAB will provide overarching scientific and clinical strategic guidance, advise on emerging trends and opportunities, and provide expert counsel on scientific and clinical matters. This press release features multimedia. View the full release here: htt...

03/18/2025 06:00
Fujirebio Europe Launches the INNO-LiPA® HCV 2.0 Genotyping Assay, an Efficient Aid to Personalized HCV Therapy

Fujirebio Europe today announced the availability* of the INNO-LiPA HCV 2.0 Genotyping assay. The product, previously distributed by Siemens Healthcare Diagnostics Inc. under the name VERSANT HCV Genotype 2.0, is a line probe assay, for in vitro diagnostic use, designed for the qualitative detection and identification of Hepatitis C virus (HCV) genotypes 1 to 6 and subtypes a and b of genotype 1 in human serum or EDTA plasma samples. Additional subtype information is available in a majority of ...